tirzepatide weight loss rate Our management program: 12 months of semaglutide, 7 months of The Story of Mounjaro (Tirzepatide)

8 Regulatory, commercial, and practical considerations in advancing underexplored peptide systems Scientific plausibility alone is insufficient to advance underexplored peptidereceptor systems into approved therapeutics

In August 2025, semaglutide (Wegovy) received FDA accelerated approval for MASH with F2 to F3 fibrosis based on the results of the ESSENCE trial

This means that while the idea of oral tirzepatide for weight loss is appealing, it hasn't been officially validated through clinical trials

On Trustpilot, where the company has more than 9,000 reviews, many users describe positive interactions, including convenience, affordability and successful weight loss outcomes

At the three month mark of oral Wegovy, clinical trial participants lost nearly 6% of their body weight

Starting at $199/mo